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introduction
Chronic diseases of lifestyle (CDL) are on the increase in South 
Africa as in the rest of the world. This increase in the number of 
communicable and non-communicable diseases has labelled South 
Africa as a country with a ‘double burden of disease.1 CDL are a 
group of diseases that share similar risk factors as a result of expo-
sure, over many decades, to unhealthy diets, smoking and lack of 
exercise and possibly stress.2 These risk factors further include inter 
alia high blood pressure, high blood cholesterol, diabetes and obes-
ity. These risk factors present in various disease processes such as 
stroke, heart attacks, certain cancers, chronic bronchitis and many 
others that culminate in high mortality and morbidity rates.3
Research has indicated that regular physical activity can positively 
address all above-mentioned pathological conditions and thereby 
reduce the mortality and morbidity rates in populations.3 Biokinetics 
has drawn on and implemented this body of evidence to prescribe 
scientifically based exercise programmes to prevent and manage 
non-communicable diseases in South Africa. In developed countries 
physical inactivity is estimated to cause 6.0% of all deaths for men 
and 6.7% for women.4 A study investigating the cost-effectiveness of 
health care-based interventions aimed at improving physical activity 
found evidence for cost effectiveness in groups with high risk, such 
as older persons and persons with heart failure.5
In South Africa, biokinetics has been practised for the last 25 
years after the scope of practice was published in the Government 
Gazette.6 Although the road to obtaining recognition was very 
difficult,
7 the profession has continued growing, with 12 training 
institutions training about 150 students every year. More than 
1 000 biokineticists have completed their training during the last 25 
years, with the current register of the Board of Health Care Funders 
(BHF) reporting 799 active practice numbers for 2009.8 The scope 
of practice for biokinetics deals with the prescription of scientifically 
based exercise for preventing and treating CDL as well as for final-
phase rehabilitation of orthopaedic injuries.9
Biokineticists usually form part of a multidisciplinary team in the 
treatment of chronic diseases and orthopaedic injuries together with 
medical practitioners, physicians, physiotherapists and dieticians. 
In the South African health care sector, however, biokineticists only 
form part of the multidisciplinary team in the private health care 
sector. Research indicates that this formal private health sector is 
a large, well-developed, resource-intensive and highly specialised 
sector that provids health insurance coverage to some 7 million 
people.10 The other estimated 40 million South Africans make use 
of either the public health care system or traditional healers, or pay 
out of their pockets for private health care services. As biokineticists 
are not employed in the public health sector, except in the National 
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abstract 
objective: Biokinetics, a profession registered with the Health 
Professions Council of South Africa (HPCSA), address inter alia 
chronic diseases of lifestyle (CDL) with exercise as treatment 
modality. The purpose of this investigation is to determine the po-
tential market demand for biokinetic services in the private health 
care sector of South Africa. 
Methods: Data from a pharmaceutical benefit management sys-
tem (PBM) were analysed to determine the prevalence of chronic 
diseases in the private health care sector for 2007. Telephonic 
interviews on a sub-sample of 50 biokineticists revealed the 
average number of patients that can be treated monthly per bioki-
neticist. The number of biokineticists with active practice numbers 
was obtained from the Board of Health Care Funders (BHF). 
results: The results indicate that 47% (747 199/1 600 000) of 
the patients managed by the PBM are treated with medication 
for one or more CDL. Non-steroid anti-inflammatory medication 
(21%), medication for cardiovascular diseases (13%) and bron-
chodilators (11%) had the highest prevalence. The sub-sample of 
biokineticists indicated that one biokineticist can treat an average 
of 100 patients per month. The potential market demand calcu-
lated from the above numbers indicated that 7 472 biokineticists 
are needed in the private health care sector, while only 625 active 
practice numbers were registered with the BHF in 2007. 
conclusion: In conclusion, it is estimated that only 7.6% of pa-
tients with CDL can potentially be treated by the current number 
of registered biokineticists. Therefore an enormous market po-
tential for biokinetics exists in the private health care sector of 
South Africa.
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Defence Force, people making use of the public health care system 
are not exposed to biokinetic intervention.
Although other health disciplines are attracted away from the 
public health sector with large financial and personal incentives,
10 
this is not the case with biokinetics. This lack of job opportunities 
in the public health sector has forced biokineticists to become 
entrepreneurs by starting private practices. These practices are solo 
practitioners, associations or partnerships with other biokineticists 
or other health practitioners. This is, however, not as straightforward 
as other entrepreneurial ventures. Strict ethical guidelines set by 
the HPCSA to guide the profession and protect the public against 
exploitation hamper biokineticists to do marketing to the same extent 
as unregistered/unregulated professions.9
In order to start any new venture, determining the market 
potential for the product is extremely important. As the purpose of 
all businesses is to create wealth, the product, price, packaging and 
place of sale should be thoroughly investigated.11 Health professionals 
are unfortunately seldom trained in business principles. This lack of 
business skills often results in the failure of biokinetic practices to be 
sustainable over a long period. This may create the perception that 
the potential market demand is too small to sustain the number of 
biokineticists trained annually. In the history of biokinetics in South 
Africa no studies have investigated the potential market demand for 
biokinetics, based on the services delivered by the profession to the 
public.
The purpose of this study was to determine the potential market 
demand for biokinetics in the private health care sector of South 
Africa. The results obtained from this investigation will shed some 
light on the potential number of biokineticists that could be trained 
per year, given no restrictions from the training institutions with 
regard to lecturing staff. 
research methodology 
Data collection
The study was an observational study to determine the potential 
market need for biokinetics. In order to understand the method- 
ology, it is important to define the market. According to Wood
12 the 
market potential is all the customers who may be interested in the 
service that is presented. It is, however, important to remember that 
some customers in this potential market are unaware of the product, 
some may not have access to it, some may not be able to use it and 
some may not be able to afford it. The potential market represents 
the maximum number of customers who might buy the product – but 
not the number who will realistically buy it.13
The approach that was followed (Fig. 1) was to determine the 
number of persons in the identified segment (persons with a chronic 
disease of lifestyle) that potentially require the service and the 
number of potential service delivery points (practising biokineticists) 
matching each other. This was performed within the South African 
private health care framework. 
For the purpose of this study, the market segment that was 
identified to base the potential market demand on was that of 
persons with CDL and orthopaedic abnormalities. Although the 
scope of practice for biokineticists9 includes the pathogenic and the 
fortogenic (health promotion) paradigms, it was decided to focus only 
on the pathogenic paradigm for the purpose of this study. Because 
secondary data were used for the analyses, it was important to ensure 
that they are timely, unbiased, legitimate, reliable and qualified.
12 In 
order to comply with these criteria, it was decided to make use of 
timely (2007), unbiased and reliable information from a private sector 
medicine claims database. The data are reliable as the database is 
created online in real time as patients collect their prescriptions. The 
geographical area, according to postal code of the consultation room 
of the prescriber, was also captured. 
The medicine claims data were from a pharmacy benefit 
management company (PBM). The PBM company administered 
medicine claims data of members of medical schemes from almost 
all community pharmacies and 98% of the dispensing doctors. For 
security, ethical, patient and provider identification reasons, PBM 
company was not identified by name.  
Prevalence of chronic diseases of lifestyle
The Niche Area: Medicine Use in South Africa (MUSA) has the rights 
to use the medicine claims database of the specific PBM for research 
purposes. Ethical clearance was obtained from the Ethics Committee 
of the North-West University (Project number: NWU-0046-08-S5). 
This system is a fully integrated management system for more than 
42 medical scheme clients administered by 17 different health care 
administrators. In 2007, 1.6 million South Africans benefited from this 
system. All medicines prescribed for chronic diseases were classi-
fied according to the coding system in the Monthly Index of Medical 
Specialties (MIMS) classification system, which classifies medicine 
according to its pharmacological action.14 A further classification of 
medicine information was performed with regard to the place (con-
sultation room) of prescriber (province, district council, municipality 
and main place level). 
The Statistical Analysis System®, SAS 9.1®15 programme 
was used to group all prescribed practice addresses according to 
province, district council, municipality and main place level. This 
allowed the researchers to identify the number of diseases treated 
with medication and the number of patients who received chronic 
medicine in different geographical areas in South Africa. 
From the database all chronic conditions where exercise is 
considered an appropriate treatment modality and that is addressed 
by biokineticists in their scope of practice as announced in the 
Government Gazette6 in 1983, were extracted to determine the 
national and provincial prevalence of the following chronic diseases 
in South Africa: hypertension, diabetes, obesity, dyslipidaemias, 
cardiovascular diseases, osteoporosis, depression and chronic 
obstructive pulmonary diseases (COPD). 
Biokineticist to patient/client ratio
In order to determine the potential market for biokinetics in the pri-
vate health care sector, the ratio of biokineticist to patient or client 
 
 
Fig. 1. A schematic presentation of the research methodological approach. 
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Fig. 1. A schematic presentation of the research methodological 
approach.
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was also determined by means of a telephone survey. Biokinetics 
practice owners registered with the Biokinetics Association of South 
Africa (BASA) website were asked to indicate the average number 
of active clients/patients treated at their facility monthly, the number 
of biokineticists and intern-biokineticists working in the practice. The 
ratio of biokineticist to patient/client was determined from this infor-
mation.
statistical analysis
Descriptive statistics with frequency tables, mean ± standard devia-
tion and graphs were performed in order to determine the market 
potential for biokinetics in the private health sector. Mathematical 
calculations were performed to calculate the potential market need 
for biokineticists. 
results
The purpose of this study is to determine the potential market de-
mand in the broad term for biokinetics in the private health care sec-
tor, specifically with reference to the pathogenic paradigm. In order 
to determine this potential demand the results will be presented by 
determining the prevalence of CDL, reporting on the physical activity 
levels of the population and the available biokineticists and practices 
that address the CDL with exercise. 
The prevalence of CDL as represented by chronic medication 
use from a medicine claims database of a PBM company indicated 
that  911 212 chronic diseases were treated within the 1.6 million 
subscribers (Table I). The average age of the persons taking chronic 
medication for diseases related to CDL was 36.8 ± 21.8 years. 
The average age was calculated according to the age at the first 
prescription date. The females were slightly older than the males 
(M=35.4±21.9 years; F=37.9±21.8 years). Totals in the table do not 
add up, as a few claims could not be placed according to geographical 
region (provinces) but are included in the calculations.
The results of Table I indicate that the prevalence of CDL is 
66% in the specific PBM database for 2007. It is however known 
that one person could be diagnosed and treated for more than one 
disease, as is often the case for persons with diabetes mellitus. The 
calculation of the number of patients represented by the prevalence 
of CDL in the PBM (Table II) indicates that 47% of persons registered 
with the PBM are treated for CDL and receiving medication for the 
CDL. The prevalence of persons with CDL is the highest in the 
Gauteng province at 19%, with the lowest prevalence the Northern 
Cape at 1%.
When the results form Table II are further divided by age and 
ratio of female/male it shows that except for gout, the ratio of women 
obtaining chronic medication is higher than for men. The average 
age of the patients also indicate that lung disease is present mainly 
in the younger population, with the average age of persons treated 
with bronchodilators at 33.0±23.2 years and those with asthma 
TaBle i. The prevalence of diseases related to chronic diseases of lifestyle receiving medication in the private 
health care sector based on a PBM company database in 2007 for the different provinces in south africa
CDL
Eastern 
Cape Free State Gauteng
KwaZulu-
Natal Limpopo
Mpuma-
langa
North-
West
Northern 
Cape
Western 
Cape TOTAL
Anti- 
depressants 9 080 8 149 50 763 16 106 6 854 5 650 7 692 2 314 14 993 122 026
Epilepsy 1 547 1 604 13 583 5 091 958 1 081 1 476 324 2 717 28 481
Parkin-
sonism
291 268 1 807 593 145 154 235 60 557 4 123
NSAID 23 214 16 022 137 497 48 487 23 156 19 820 23 304 5 130 33 836 332 173
Gout 1 333 994 7 708 2 113 913 1 150 999 233 2 196 17 681
Osteopo-
rosis
855 607 4 815 1 670 211 292 429 100 1 851 10 872
CVD 210 248
Inotropic 
agents
507 495 2 384 1 028 286 259 310 131 925 6 345
Arrhyth-
mias
258 478 2 155 610 83 157 210 66 735 4 774
Hyperten-
sion
11 570 9 249 66 102 22 151 6 365 6 945 8 467 2 455 23 559 157 354
Angina 4 553 3 012 19 081 7 236 2 613 2 415 2 869 10 704 7 588 50 587
Vasodilator 50 104 782 97 54 69 142 32 107 1 444
Vasocon-
strictors 
233 270 2 746 514 156 303 386 89 442 5 138
Hyperlipi-
daemia 
6 393 4 166 36 455 10 509 1 986 2 891 3 519 875 14 133 81 204
Bronchodi-
lators 
12 471 7 639 27 495 11 095 10 548 12 764 2 739 21 642 175 277
Asthma 2 478 2 533 19 964 6 463 3 479 1 959 3 083 508 4 805 45 367
Diabetes 3 388 2 335 19 638 7 981 2 557 2 129 2 586 693 6 010 47 459
  Total 76 543 45 905 403 129 135 009 54 314 45 662 46 683 11 029 92 774 911 212
CDL = chronic diseases of lifestyle; NSAID = non-steroid anti-inflammatory drugs; CVD = cardiovascular disease.
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medication 32.6±25.3 years. The average age of people obtaining 
medication for cardiovascular diseases is 60 - 70 years. Non-steroid 
anti-inflammatory medication (NSAID) is mostly prescribed to 
persons around the age of 45 years. This may be due to the onset of 
arthritis and joint and muscle pain from previous injuries.
The calculation from Fig. 2 indicates that from 1.6 million persons, 
747 199 persons are on medication for a CDL that could be treated 
through exercise intervention such as presented by biokineticists. 
This is further divided into 316 894 persons suffering from a single 
disease and the rest treated for more than one disease within the 
CDL. The prevalence of participants on anti-inflammatory medication 
is the highest (21%), followed by patients who received medication for 
cardiovascular diseases (13%) and then patients on bronchodilators 
(11%) and medication for hypertension (10%). 
Physical inactivity profiles of South Africans
As biokineticists address CDL with exercise as treatment, it is also 
important to report on the current levels of physical inactivity as it 
is a risk factor for CDL.3 Secondary data reported in the South Afri-
can Health Review10 compared the levels of inactivity reported in the 
general population with those reported in a corporate survey (Table 
III). The results indicate that about 50% of the general population 
does not participate in levels of physical activity that would reduce 
or manage CDL. 
current biokinetic practices
In order to determine the market potential, the current number of 
biokineticists who render this service had to be determined. The 
number of practising biokineticists according to the BASA website, 
which is an optional place to register and not compulsory (Table IV), 
indicates 284 biokinetic practices. Seventy-one of the 284 practices 
are accredited to employ biokinetic interns (students in training who 
have to complete a final year of practical training before final regis-
tration with the HPCSA can be obtained). These practices may em-
ploy more than one biokineticist and a maximum of two interns per 
registered biokineticist.9
Data obtained from the BHF,8 the management system for practice 
numbers that enables biokineticists and patients to claim from 
medical insurance, indicate 625 biokineticists with active practice 
numbers who were also registered with the HPCSA in 2007. The 
distribution of these practices within South Africa (Table IV) indicates 
that the majority of the practices are in the Gauteng province (130), 
with the second most in the Western Cape (63). This means that 
46% of biokineticists are practising in and around Gauteng, while 
about 22% of the total pool of practising biokineticists is active in the 
Western Cape. This leaves about 32% of the biokineticists in the rest 
of South Africa.
ratio of biokineticist to patient/client 
A telephonic interview with 50 randomly selected available bioki-
neticists indicated that each biokineticist could manage about 100 
 1
 
Fig 2. The prevalence (%) of disease in participants on the PBM database taking 
medication for the different chronic diseases of lifestyle. (NSAID = 
non-steroid anti-inflammatory drugs; CVD = cardiovascular disease
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Fig 2. The prevalence (%) of disease in participants on the PBM 
database taking medication for the different chronic diseases of 
lifestyle. (NSAID = non-steroid anti-inflammatory drugs; CVD = 
cardiovascular disease.)
TaBle ii. Prevalence of cDl according to the number of persons diagnosed and treated with medication for each 
of the provinces and in relation to the estimated population
Provinces estimated population Persons with cDl % of the estimated population
Eastern Cape 6 906 200§ 46 503 2.9
Free State 2 965 600§ 33 110 2.1
Gauteng 9 688 100§ 300 659 18.8
KwaZulu-Natal 10 014 500§ 112 948 7.1
Limpopo 5 402 900§ 47 221 2.9
Mpumalanga 3 536 300§ 42 221 2.6
North-West 3 394 200§ 49 895 3.1
Northern Cape 1 102 200§ 11 271 0.7
Western Cape 4 839 800§ 100 343 6.3
Not indicated 3 028 0.2
   Total 47 849 800§ 747 199 46.7
§
Total mid-year population estimates, 2007.
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TaBle iii.  a summary of the prevalence (%) of phys-
ical inactivity reported in different surveys
surveys Total (%) Males (%)
Females 
(%)
51-country survey17 46.2 44.7 47.6
Youth risk behaviour18 36.8 30.5 43
Corporate survey19 69 62 75
SADHS20 46 43 49
World Health Survey21 46 43 49
SADHS = South African Demographic and Health Survey.
18               saJsM  vol 23  no. 1  2011
(range 40 - 160) patients per month depending on the type of prac-
tice and the business strategy followed. There was an average of 2 
biokineticists working in each practice. If every biokineticist managed 
100 clients in South Africa from the specific PBM, where 747 199 
clients are treated for CDL, then 7 438 biokineticists will be required 
in South Africa. Table IV indicates the current number of practising 
biokineticists with regard to each province together with the market 
potential based on the prevalence of chronic disease as indicated by 
the PBM system.
Discussion
CDL are a reality in South Africa, a country with a double burden of 
disease that is created between CDL, also known as non-communi-
cable diseases, and the infectious diseases such as HIV/AIDS and 
tuberculosis, also known as communicable diseases. The results of 
this study indicate that the prevalence of the CDL in this PBM system 
is 56% and represent 47% patients. The major three conditions rep-
resent nearly a third of all the total medicine expenditure managed 
by this studied PBM. This is much higher than the reported 37% 
of deaths attributed to CDL.18 Considering that most of the surveys 
report on data that were obtained either during 199820 (SADHS) or 
until 2005,2 it is therefore possible that the prevalence of CDL has 
increased substantially since the last survey.
Although the percentages are not very high, the corresponding 
numbers of persons who require treatment are substantial. If these 
percentages of prevalence for the various CDLs are extrapolated 
to the general population, estimated to be 47 498 00016 (StatsSA, 
2009) at June 2007, it could mean that about 26 795 888 people in 
South Africa are diseased by one of the CDLs. Steyn et al.2 report 
that about 6 million people are living with hypertension, 4 million with 
diabetes and about 4 million have hyperlipidaemia. Steyn et al.2 also 
mention that about 56% of the population has at least one of these risk 
factors. The prevalence of CDL as found in this investigation based 
on the prescription of medication, observed comparable prevalence 
for hypertension and diabetes as reported by Puoane et al.23 Studies 
investigating the cost of managing CDL have highlighted the burden 
of CDL on an economy. 23,24
When interpreting the data on CDL from a biokineticist’s point 
of view, it is important to also consider the inactivity patterns in 
South Africa. The results indicate that females are more inactive 
than males, with people in the corporate sector reporting inactivity 
levels of close to 70% in the total for males and females.10 This is a 
daunting number of physically inactive persons who are often also 
exposed to high levels of stress in the work environment. These high 
levels of physical inactivity indicate that there is a huge potential for 
the management of chronic diseases with exercise and physical 
activity interventions, as the majority of the population are currently 
not participating in the required amount of activity as prescribed by 
the ACSM3 to achieve health outcomes. 
The results of the number of biokineticists registered with the 
HPCSA that also have active practice numbers indicate that the 
approximately 625 biokineticists are most likely accommodated 
within the 284 biokinetics practices in South Africa. These are 
crude delineations as it is impossible to obtain the exact number of 
biokineticists who are actively earning a living as biokineticists. The 
reason is that persons on the register of the HPCSA continue to pay 
registration fees annually to ensure they stay on the role, even if they 
are not practising, in order to keep their registration. The reason for 
this behaviour is that it is difficult to obtain registration again once 
you have been deregistered and have not practised for a number of 
years. Another reason for inaccurate numbers on the BASA website 
is the fact that it is optional to register practices on the website. In 
spite of the inaccurate numbers, the data described are still the most 
accurate available that were used in the analysis and assumptions 
made.
The distribution of the biokinetics practices simulate the areas 
of high income in South Africa, with the most practices being in the 
Gauteng area and the least practices in the Northern Cape, which has 
the lowest income per capita.16 The population density in Gauteng is 
also higher than in the Northern Cape, resulting in shorter travelling 
distances between home and biokinetic practices. The analyses of 
the number of patients/clients that a biokineticist is able to treat per 
month indicated an average of 100 persons with a range of between 
40 and 160. There was an average of 2 biokineticists working per 
accredited practice. 
In order to calculate the potential market demand for biokinetics, 
the potential number of persons taking medication for CDL according 
to the analysed PBM system was divided by 100 to determine the 
number of potential biokineticists needed. This calculation indicated 
that about 7 438 biokineticists are needed. If an average of two 
persons work together, that means that about 3 719 practices are 
potentially needed. The current number of biokinetic practices is 
therefore calculated to be rendering a service to only 8% of the 
potential market. As these are pure calculations to determine the 
market potential, it is necessary to take into account the factors 
that may hamper people from visiting a biokineticist for exercise as 
treatment of a CDL. 
When calculating a market potential, the broadest market is 
first determined,
12 as was done with this study. It is important to 
remember that these results are a crude indication of the potential 
market demand for biokinetics in the private health care sector. This 
study also only focused on the pathogenic paradigm, and not the 
fortogenic (health promotion) paradigm, where biokinetic intervention 
addresses the prevention of CDL. The section of the market that has 
the income to afford the service and has access to the product should 
be determined. Important factors that can influence the behaviour of 
the potential consumers will include gender, level of education, age, 
ethnic background and the perceived value for the client/patient, 
TaBle iv. The relationship between the current 
number of practising biokineticists and the potential 
market need for the different provinces
Province
current number of 
practices (N)
Market need 
for biokineti-
cists* (N)
Eastern Cape 19 465
Free State 11 331
Gauteng 130 3 006
KwaZulu-Natal 33 1 129
Limpopo 5 472
Mpumalanga 9 422
North-West Province 11 498
Northern Cape 3 112
Western Cape 63 1 003
   Total 284 7 438§
*Based on 100 patients/biokineticist. 
§Numbers differ due to some claims not being linked to original place of prescribing 
of medication. 
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various social connections and personal elements, of which lifestyle 
would be the most prominent together with motivation.
A study investigating the factors that influence the demand for 
health care in South Africa using a multinomial logit estimation, found 
that there are three categories of factors that influence the demand. 
These factors are: (i) demographic and location variables (e.g. 
income, race and location); (ii) characteristics of the care provided 
(e.g. cost and distance from the respondent); and (iii) characteristics 
of the illness (such as severity).25 This study also found that an 
increase in income indicated a decrease in the use of primary health 
care. Where income was above R2 785 per month, primary health 
care was only utilised in less than 5% of the respondents.25 These 
results give an indication of the income group that can be expected 
to seek treatment for CDL as offered by biokinetics.
The limitations of this study were that the numbers on which 
the calculations are based are relative, although currently the most 
accurate available. The calculations from the PBM are also based 
on the prevalence of the 2007 data, as the classification of the 2008 
data is not available. The number of biokineticists is also a crude 
number as accurate numbers are difficult to obtain. Registered 
biokineticists often become pharmaceutical representatives to earn 
a larger income while also learning business and marketing skills 
before returning to the profession. 
conclusions 
The conclusion that can be drawn from this study is that there is a 
large potential market for biokinetics in the private health care sector 
of South Africa. Currently only an estimated 8% of the potential mar-
ket is addressed by biokinetics with exercise as a treatment modality. 
This is only the calculation for the pathogenic paradigm. It therefore 
seems that the number of biokineticists trained annually could be 
increased to address the shortage in the market. However, an inves-
tigation is recommended to determine the factors that may prevent 
the large potential market demand from realising. 
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